ACT Genomics drives innovation in global standard and individual markets, winning Taiwan Bio Industry Organization Awards- Emerging Company of the Year. Among all parties in cancer genomic profiling service's industry, ACT Genomics establishes a comprehensive cancer genomic profiling service system ahead in Asia. From 2014, ACT Genomics has aquired international certificates and awards as a rising star, and standardize immunotherapy biomarker in international TMB project as the only Asia representative, and use a series of clinical services to get thousands of genetic testing results in Taiwan, Singapore, Hong Kong, Japan, and China.
六福彩票Full News :
MoreTaiwan Bio Industry Organization Awards News :